In this study, we attempted to understand the underlying mechanisms by which EphA2 over expression leads to enhanced or irregular claudin-2 expression via cdx-2 modulation and promote tumor growth in NSCLC cells. The gene discussed is EPHA2; the disease is neoplasm.